TABLE 2.
Neutralizing antibody data from control animals at various weeks after challenge with SIVmac239
Animal | wk postchallenge | Neutralizing antibody titera to:
|
|
---|---|---|---|
SIVmac251 | SIVmac239 | ||
90069 | 0 | <20 | <20 |
3 | <20 | <20 | |
6 | 856 | <20 | |
10 | 1,755 | <20 | |
90131 | 0 | <20 | <20 |
3 | <20 | <20 | |
6 | <20 | <20 | |
10 | <20 | <20 | |
92050 | 0 | <20 | <20 |
3 | 42 | <20 | |
6 | 919 | <20 | |
10 | 651 | <20 | |
92080 | 0 | 20 | <20 |
3 | 341 | <20 | |
6 | 2,139 | <20 | |
10 | 1,641 | <20 | |
97086 | 0 | 25 | <20 |
3 | 419 | <20 | |
6 | 8,010 | <20 | |
10 | 9,952 | <20 |
Reciprocal serum dilution at which 50% of CEMx174 cells were protected from virus-induced killing, as measured by neutral red uptake. SIVmac251 was laboratory adapted.